USPTO serial 76081975
ALBUTROPIN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- HALL, MICHAEL E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALBUTROPIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHRISTY BATY HEINZE
CHRISTY BATY HEINZE FINNEGAN, HENDERSON, FARABOWGARRETT & DUNNER LLP1300 I ST NWWASHINGTON, DC 20005-3315Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATION, NAMELY FUSION PROTEIN FOR TREATMENT OF GROWTH HORMONE DEFICIENCY | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HUMAN GENOME SCIENCES, INC.
- Other trademarks owned by Principia Pharmaceutical Corporation
- Other trademarks owned by Principia Pharmaceutical Corporation
- Other trademarks in Class 005
- Similar marks named ALBUTROPIN
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 16, 2004 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 1, 2004 | CFIT | CASE FILE IN TICRS | — |
| Feb 16, 2004 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 20, 2004 | PAPER RECEIVED | — | |
| Jan 17, 2004 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 26, 2003 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 17, 2003 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 17, 2003 | PAPER RECEIVED | — | |
| Apr 11, 2003 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 17, 2003 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 17, 2003 | PAPER RECEIVED | — | |
| Aug 8, 2002 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 17, 2002 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 17, 2002 | PAPER RECEIVED | — | |
| Jan 14, 2002 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 14, 2001 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 17, 2001 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 24, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 11, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 4, 2000 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2000 | DOCK | ASSIGNED TO EXAMINER | — |